EMSAM

LOE Approaching

selegiline

NDATRANSDERMALFILM, EXTENDED RELEASE
Approved
Feb 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1

Mechanism of Action

Monoamine Oxidase Inhibitors

Pharmacologic Class:

Monoamine Oxidase Inhibitor

Indications (1)

major depressive disorder (MDD) ()

Clinical Trials (1)

NCT00443872Phase 4Completed

Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists

Started Mar 2007
77 enrolled
Parkinson's Disease
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers